ArticlePharmacoepidemiology and drug safety2022

The risk of melanoma with rasagiline compared with other antiparkinsonian medications: A retrospective cohort study in the United States medicare database.

Catherine B Johannes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.